Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q1 2024 vs. Q4 2023
How the institutions holding Biofrontera Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 8 | 11 | +3 |
| Shares | 9.46K | 1.09M | +1.08M (+11,380.9%) |
| Value | $26.2K | $1.67M | +$1.64M (+6,267.6%) |
New holders (6)
Institutions that held Biofrontera Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rosalind Advisors, Inc. | 504,261 | $776.6K | 0.73% |
| AIGH Capital Management LLC | 501,434 | $766.2K | 0.37% |
| Scotia Capital Inc. | 40,000 | $61.6K | 0.00% |
| XTX Topco Ltd | 12,185 | $18.8K | 0.00% |
| Renaissance Technologies LLC | 10,221 | $16.0K | 0.00% |
| HRT Financial LP | 10,639 | $16.0K | 0.00% |
Sold out (3)
Institutions that held Biofrontera Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| JPMorgan Chase & Co | 825 | $2.29K |
| Morgan Stanley | 200 | $554 |
| Bank of America Corp | 11 | $30 |